Company Analysis
Sign in

Voyager Therapeutics, Inc. (VYGR)

Nasdaq: VYGR · Biological Products, (No Diagnostic Substances) · Lexington, MA · filing with the SEC since 2015
Full chart Alerts Compare
Grade5.4
◀ Past 6.1● Present 5.6▶ Future 4.3
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

42 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Voyager Therapeutics, Inc.’s names, not what it holds today.

Patents granted
42
42 utility, 1976 to Dec 31, 2025
Granted in 2025
8
Against 12 in 2024 and 5 in 2023
Applications published
124
17 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology21
Pharmaceuticals14
Medical technology2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
VOYAGER THERAPEUTICS, INC. its own name
named as the applicant on its applications, in US
0 granted
116 published
VOYAGER THERAPEUTICS, INC. its own name
US, as the owner printed on each patent. 5 more under the same name are not counted (printed in GB)
42 granted
8 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Nov 11, 202512,467,046Redirection of tropism of AAV capsidsBiotechnologyVOYAGER THERAPEUTICS, INC.
Sep 23, 202512,419,969AAV capsid variants and uses thereofPharmaceuticalsVOYAGER THERAPEUTICS, INC.
Jun 3, 202512,319,929Compositions and methods for the treatment of Parkinson's diseasePharmaceuticalsVOYAGER THERAPEUTICS, INC.
May 20, 202512,305,189Compositions and methods for delivery of AAVBiotechnologyVOYAGER THERAPEUTICS, INC.
May 13, 202512,296,025AAV capsid variants and uses thereofPharmaceuticalsVOYAGER THERAPEUTICS, INC.
May 6, 202512,291,565Tau binding compoundsPharmaceuticalsVOYAGER THERAPEUTICS, INC.
Apr 22, 202512,281,321Frataxin expression constructs having engineered promoters and methods of use thereofPharmaceuticalsVOYAGER THERAPEUTICS, INC.
Mar 18, 202512,252,703Closed-ended linear duplex DNA for non-viral gene transferPharmaceuticalsVOYAGER THERAPEUTICS, INC.
Dec 31, 202412,180,500Chimeric capsidsBiotechnologyVOYAGER THERAPEUTICS, INC.
Nov 19, 202412,146,150Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous deliveryBiotechnologyVOYAGER THERAPEUTICS, INC.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 25, 20252025/0388626AAV CAPSID VARIANTS AND USES THEREOFBiotechnologyVOYAGER THERAPEUTICS, INC.
Nov 13, 20252025/0346920BACULOVIRUS EXPRESSION SYSTEMBiotechnologyVOYAGER THERAPEUTICS, INC.
Sep 25, 20252025/0295809COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2 POSITIVE CANCERPharmaceuticalsVOYAGER THERAPEUTICS, INC.
Sep 18, 20252025/0290094CLOSED-ENDED LINEAR DUPLEX DNA FOR NON-VIRAL GENE TRANSFERPharmaceuticalsVOYAGER THERAPEUTICS, INC.
Sep 11, 20252025/0282854TAU BINDING COMPOUNDSPharmaceuticalsVOYAGER THERAPEUTICS, INC.
Jul 31, 20252025/0243263TAU BINDING COMPOUNDSPharmaceuticalsVOYAGER THERAPEUTICS, INC.
Jul 17, 20252025/0228967AAV CAPSID VARIANTS AND USES THEREOFPharmaceuticalsVOYAGER THERAPEUTICS, INC. · patent 12,419,969 granted from it
Jul 10, 20252025/0223376COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2 POSITIVE CANCERPharmaceuticalsVOYAGER THERAPEUTICS, INC.
Jul 3, 20252025/0215453AAV CAPSID VARIANTS AND USES THEREOFBiotechnologyVOYAGER THERAPEUTICS, INC.
May 22, 20252025/0161485AAV CAPSID VARIANTS AND USES THEREOFBiotechnologyVOYAGER THERAPEUTICS, INC.
What it applied for, 2024 to 2025: Pharmaceuticals 15 · Biotechnology 15 · Medical technology 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton VYGR · research, not advice